Efficacy and Safety of Chimeric Antigen Receptor T Cells Therapy Strategy That Dual Targeting CD19 and CD22 to Treat Relapsed/Refractory Acute Lymphoblastic Leukemia in AdultsSanfang Tu,Lijuan Zhou, Rui Huang,Xuan Zhou,Jilong Yang,Meifang Li,Bo Jin,Langqi Wang,Yaqi Zhuo,Huifang Chen,Lung-Ji Chang,Yuhua LiBLOOD(2023)引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要